 | Celldex Therapeutics, Inc. | |||
| NCM : CLDX || Location: United States | ||||
$36.84-0.18 (-0.49%) |
0.22 M | 35.86 - 37.15 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 6.750 M |
| March 28, 2024 | 6.558 M |
| March 15, 2024 | 5.897 M |
| Feb. 29, 2024 | 6.411 M |
| Feb. 15, 2024 | 6.941 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.76 | -0.83 | -9.41% |
| 09/30/2023 | -0.69 | -0.81 | -17.04% |
| 06/30/2023 | -0.68 | -0.65 | 4.41% |
| 03/31/2023 | -0.64 | -0.62 | 3.82% |
| 12/31/2022 | -0.60 | -0.56 | 6.95% |
CLDX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 65.699M | Shares Float | 52.738M |
| Short Float | 6.750M | Market Cap | 2432.18M |
| Institution ownership | 97.00% | Insider ownership | 0.347% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.92 | Forward EPS | -3.09 |